Such a type of self-sufficiency or autonomy in a cancer cell obviates its need to depend exclusively on the surroundings, especially during the intravascular journey (when CTCs cannot access biologically active EGF) and during the initial phase of avascular growth of a CTC that has just extravasated to a new site. The gene discussed is EGF; the disease is cancer.